Skip to main content
Get Alerts

Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to September 2026.

36,949
Total recall recordsAll FDA and USDA recalls in Public Health Trace
9,732
Class I recallsReasonable probability of serious health consequences
24,263
Class II recallsTemporary or medically reversible health consequences
2,873
Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls
Most common hazardLack of Assurance of Sterility 2,071 recalls
Newest recallhttp://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/foods-alive-recalls-organic-moringa-leaf-powder-because-possible-health-riskPublished September 4, 2026
Most affected stateHawaii 200 recalls mention this state

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters
Recall details
Location
Date range
Sort results
Clear filters
Metric
View
Recalls announced by month (Year to date)

A chart of recalls grouped by month.

Download CSV

Source: FDA and USDA public dataLast updated

Summary (Year to date)

  • 1,458 recalls have been announced year to date.
  • Aug 2026 was 53% lower than the previous complete period (Jul 2026: 240).
  • The highest complete period was Jun 2026 (297).
  • Sep 2026 is incomplete and not included in the figures above.
  • Complete data
  • Incomplete
Recalls by class

A bar chart of the total number of recalls in this dataset by recall class.

Recalls by class
ClassRecalls
Class II24,263
Class I9,732
Class III2,873
Not Yet Classified1
Download CSV
Recalls by class
ClassRecalls
Class II24,263
Class I9,732
Class III2,873
Not Yet Classified1

Showing 101–120 of 18,300 recalls

FDA Recall Ongoing 2026 recordClass II

Revitaderm Wound Care, First Aid Antiseptic Gel, Benzalkonium Chloride 0.1%) packaged as (a) 1.0 Fl OZ (16 mL) bottle, long pointy cap, NDC 63347-120-02; (b) 3.0 Fl OZ (85 g) tube, with short twist cap, NDC 63347-120-01; Manufactured By: Blaine Labs, Inc. 11037 Lockport Place, Santa Fe Springs, CA 90670,

by Blaine Labs Inc

Reason
CGMP Deviations; product manufactured in the same facility under the same conditions as the product found to be contaminated
Published
July 8, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass II

Fungal Fusion ERADICATION Solution, Antifungal & Antimicrobial Kit. Contains, 1x2 oz bottle Fungal Fusion Antifungal (Miconazole Nitrate) Cream, 1x2oz bottle Fungal Fusion Antifungal Solution (25% Undecylenic Acid) and 1x1oz bottle of Fungal Fusion Eradication Antimicrobial Show Spray (isopropyl Alcohol, D-Limonene, Undecylenic Acid). Manufactured By: Blaine Labs, Inc., 11037 Lockport Place, Santa Fe Springs, CA 90670, Manufactured for Doctor's Inc

by Blaine Labs Inc

Reason
CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry
Published
July 8, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass II

TERPENICOL Antifungal Solution, (Undecylenic (10-Undecenoic) acid 25%), 1.0 Fl Oz (29.6 mL), Manufactured By: Blaine Labs, Inc., 11037 Lockport Place, Santa Fe Springs, CA 90670. NDC 63347-600-01

by Blaine Labs Inc

Reason
CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry
Published
July 8, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass II

vite20 Antifungal Cream, (10% Undecylenic Acid), 0.54 OZ (15 g) bottle, Manufactured By: Blaine Labs, Inc., 11037 Lockport Place, Sante Fe Springs, CA 90670, UPC 6 16728 00039 2.

by Blaine Labs Inc

Reason
CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry
Published
July 8, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass II

TERPENICOL Antifungal Cream (Undecylenic Acid 13%), 1.0 oz (28 g) bottles, Manufactured By: Blaine Labs, Inc., 11037 Lockport Place, Sante Fe Springs, CA 90670, NDC 63347-601-01.

by Blaine Labs Inc

Reason
CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry
Published
July 8, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass II

TRIPENICOL S Antifungal Solution (Undecylenic Acid 25%), 1.25 FL OZ (37.5 mL) bottle, Manufactured For: Trifluent Pharma, LLC, San Antonio, TX 78213, NDC 73352-550-01.

by Blaine Labs Inc

Reason
CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry
Published
July 8, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass II

TRIFLUENT PHARMA TRIDERGEL Wound Care Gel, (Benzalkonium Chloride 0.1%), 1.0 fl oz, (29.6 mL) bottle with long pointy cap, Manufactured for: Trifluent Pharma, LLC. San Antonio, TX 78213. NDC 73352-520-01.

by Blaine Labs Inc

Reason
CGMP Deviations: product manufactured in the same facility under the same conditions as the product found to be contaminated
Published
July 8, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass I

Revitaderm Wound Care Gel, Benzalkonium Chloride 0.1%, packaged in 1.0 FL OZ (37 mL) bottle, shorter twist cap, Manufactured By: Blaine Labs, Inc. 11037 Lockport Place Santa Fe Springs, CA 90670, NDC 63347-120-02.

by Blaine Labs Inc

Reason
Microbial contamination of Non-Sterile Product: samples identified the presence of Lysinibacillus fusiformis and other Bacillus spp
Published
July 8, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass II

Cinacalcet Hydrochloride Tablets, 90 mg, 30-count bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC, Patalganga, India; Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059, NDC 69097-412-02

by Cipla USA, Inc.

Reason
cGMP Deviations: presence of N-nitroso-cinacalcet, above the acceptable daily intake (ADI).
Published
July 8, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass II

Cinacalcet Hydrochloride Tablets, 60 mg, 30-count bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC, Patalganga, India; Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059, NDC 69097-411-02

by Cipla USA, Inc.

Reason
cGMP Deviations: presence of N-nitroso-cinacalcet, above the acceptable daily intake (ADI).
Published
July 8, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass II

Cinacalcet Hydrochloride Tablets, 30 mg, 30-count bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC, Patalganga, India; Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059, NDC 69097-410-02

by Cipla USA, Inc.

Reason
cGMP Deviations: presence of N-nitroso-cinacalcet, above the acceptable daily intake (ADI).
Published
July 8, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass II

Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate Extended-Release Capsules, 5 mg, Rx Only, 100 capsules, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136, NDC: 0527-0790-37.

by Lannett Company Inc.

Reason
Labeling: Label Mix-up: Capsules contain only immediate-release (IR) pellets while labeled as ER capsules.
Published
July 8, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass II

Lidocaine HCl Injection USP, 1% (10 mg/mL), 5 mL single dose ampule, Rx Only, Distributed by Enovachem Pharmaceuticals, Torrance, CA 90501, NDC: 85766-187-01.

by Asclemed USA Inc.

Reason
Lack of Assurance of Sterility
Published
July 8, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass II

Accucaine, Kit contains: Lidocaine HCl Injection USP, 1% (10 mg/mL), 5 mL single dose ampule, Rx Only, Distributed by Enovachem Pharmaceuticals, Torrance, CA 90501, NDC: 76420-715-01.

by Asclemed USA Inc.

Reason
Lack of Assurance of Sterility
Published
July 8, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass II

Levothyroxine Sodium Tablets, USP, 300 mcg (0.3mg), 90 Tablets bottles, Rx only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: lntas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, INDIA, NDC 16729-458-15.

by ACCORD HEALTHCARE, INC.

Reason
Subpotent Drug
Published
July 8, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass II

prednisoLONE Acetate Ophthalmic Suspension, USP, 1%, Rx only, Sterile, a) 5 mL (NDC 70748-332-02); b) 10 mL (NDC 70748-332-03), c) 15 mL (70748-332-04), Manufactured by: Lupin Limited, Pithampur (M.P) 454 775, INDIA

by Lupin Pharmaceuticals Inc.

Reason
Presence of Foreign Substance
Published
July 8, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass III

Fexofenadine Hydrochloride Tablets, USP 180 mg, Antihistamine, 150 Tablets per bottle, Distributed by: Ohm Laboratories, Inc., New Brunswick, NJ 08901. NDC 66336-561-30

by SUN PHARMACEUTICAL INDUSTRIES INC

Reason
Failed Impurities/Degradation Specifications
Published
July 8, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass II

IMULDOSA, (ustekinumab-srlf) Injection, 130 mg/26 mL (5mg/mL), Rx only, Single dose vial, Manufactured by Accord BioPharma Inc., 8041 Arco corporate Drive, Suite 200, Raleigh, NC 27617, USA, Manufactured at: Catalent Indiana, LLC, 1300 S. Patterson Drive, Bloomington, IN 47403, USA, NDC 69448-019-26.

by ACCORD BIOPHARMA INC

Reason
Lack of assurance of Sterility:
Published
July 8, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass II

BD ChloraPrep CLear, (2% w/v chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol) 100 x 10.5 mL Applicators/case, STERILE SOLUTION, CareFusion 123, LLC, El Paso, TX, subsidiary of Beckton, Dickson and Co. NDC 54365-400-34, catalog number 930700NS.

by CareFusion 213, LLC

Reason
Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of the intended distribution channel
Published
July 8, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass II

BD ChloraPrep CLear, (2% w/v chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol),500 x 1 mL applicators/case, STERILE SOLUTION, CareFusion 123, LLC, El Paso, TX, subsidiary of Beckton, Dickson and Co. NDC 54365-400-31, bulk catalog number 930480NSB

by CareFusion 213, LLC

Reason
Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of the intended distribution channel
Published
July 8, 2026
Distribution
Nationwide

View recall →

Data last updated:

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.